S2 prescription not needed to buy Chinese drug Lianhua Qingwen — FDA
MANILA, Philippines — Chinese drug Lianhua Qingwen (LQ) may now be bought without a prescription from a doctor licensed by the Philippine Drug Enforcement Agency (PDEA), Food and Drug Administration (FDA) Director-General Eric Domingo said.
During a House health committee hearing on Tuesday, Domingo announced that the Dangerous Drugs Board (DDB) recently delisted traditional Chinese medicine as a dangerous substance.
“Lianhua has been registered with the FDA since last year. This is registered as a traditional Chinese medicine for pulmonary conditions,” he said.
“It has recently been delisted by the Dangerous Drug Board as a dangerous drug kasi po yung ephedra (ephedrine),” according to Domingo.
As a result, the patient does not need an S2 prescription to purchase it, he added.
An S2 prescription can only be issued by a physician with an S2 license from PDEA.
The FDA chief later told INQUIRER.net that the Chinese drug is “still a prescription medicine.”
“[A] regular doctor’s prescription will do,” he said.
Recently, the therapeutics and medication safety committee (TMSC) of Makati Medical Center said people should not take Chinese medicine without a doctor’s prescription.
According to the hospital, this medicine contains “ma huang” from which ephedrine is extracted.
Ephedrine, which is used to treat low blood pressure symptoms during anesthesia, is considered a harmful medication under the law and can only be administered by a physician with an S2 authorization granted by PDEA.
The FDA previously stated that Lianhua is not registered as a COVID-19 medication in the Philippines, but only traditional Chinese medicine.
READ: FDA: Approved Chinese drug not for treating Covid-19
The drug’s certificate of product registration for the Philippines claimed that it can help eliminate heat toxin invasion of the lungs, including symptoms such as fever, aversion to cold, muscle soreness, stuffy and runny nose.
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.